Orchard Therapeutics PLC (NASDAQ:ORTX)

BATS BZX Real-Time Price
As of 1:27pm ET
 +0.0268 / +4.15%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +569.14% increase from the last price of 0.67.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Orchard Therapeutics PLC. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 26.07%
Growthannually 18.16%


Growthquarterly -36.61%
Growthannually 908.65%
Key to the earnings and sales forecast charts.